Member Info for Miggy007

FOMO

I actually think not many people will want to be out of this the weekend in case positive news lands or more possibly media coverage. Worst case scenario this doesnt work shares based on COPD and Asthma potential are still worth 40p. May well go lower on negative news but they'll bounce back. Positive news and the sky is the absolute limit with such a ridiclous market cap!. I'll keep the faith Bixy while hopefully your crapping yourself you didnt jump on board!:)GLA

Iamrich- I cannot see the home trial being included in current trial that is a different animal tbh.

Thought Richard CEO was quite keen to stress the treatment in the home scenario. Taking in other events occuring currently it seems crucial to grab the virus early to stop replication leading in the more severe cases to a ventilator which is only a 50-50 chance of survival. Great to read that sleep apnoea devices are being altered to keeping people alive and by the sounds of it much better rates of turnaround than a ventilator. I can see the scenario (at least until a vaccine is discovered) is for a pre-emptive drug like SNG001 to be used upon early contraction of virus and those who slip through the net or condition worsens after treatment to be placed on a breathing assistance device rather than a ventilator. Any thoughts?

I think Gilead Sciences market cap is about 96 billion. SNG's is currently 94 million. Could David beat Goliath!!!

That would be the recovery trial I believe. They were up to 5,000 last time i heard

Ghia- I think the results probably around a couple of weeks away too. exciting times. Would have thought people will start to get a bit nervous being out of this stock now. Thought the peak today would be about 68p but Friday tomorrow and i wouldnt want to be out of this stock over the weekend so didnt give too much thought to slicing.

Was watching the share when it kicked off. I felt that the MM's had been holding it back this morning prior to the youtube video of CEO. So when that landed and it snowballed it could only head one way. Can't keep a good share down. Following my earlier post i still think this share is way undervalued. I cant believe trial results will be negative given Richards apparent confidence.

i know Maqsood, but their is saying it and then the follow up action collaborating it :)

Certainly sounded like the trials must be going well reading between the lines. Why else would the CEO be talking about scaling up in Nebulisers and SNG001 to distribute in the millions!!. Plus the comment "it's our time", quite striking.

One perfect scenario for this product is being able to take it from home. So many upsides to that. Avoids a hospital visit which people are avoiding if at all possible. No bed or injection required. Main thing is that people take this product quickly before the viral load multiplies greatly thus avoiding the need for a hospital bed/filters. Get the drug made and the nebulisers and all goes well with testing then out to the care homes and people in dire need.

Have to say im quite stunned the SP is not higher than current level, great oppo to buy in.

BBC i PLAYER Adam at 9.30am or thereabouts

Won't be in his bottom JM:)

Jack-allis - Great find, noted part of the conclusion to one of these reports, University of Texas:

Overall, our results indicate that SARS-CoV-2 has a much higher sensitivity to type I IFN
182 than the previously emergent SARS-CoV. This augmented type I IFN sensitivity is likely due to
183 changes in viral proteins between the two epidemic CoV strains. Moving forward, these data
184 could provide important insights for both the treatment of SARS-CoV-2 as well as developing
185 novel animal models of disease. In this ongoing outbreak, the results also highlight a distinction
186 between the highly related viruses and suggest insights from SARS-CoV must be verified for
187 SARS-CoV-2 infection and disease.

Great find indeed!.
The UHB site says that drugs can be added and removed from the recovery trial depending on study and review. I strongly suspect that SNG001 would be added to that if results are positive in the pilot trial SG016.

https://www.uhb.nhs.uk/news/prioritising-covid-19-research.htm

Erm, hydroxy chloroquine isn’t working too well. Thank god Trump isn’t in charge over here. Proves you need to do proper trials.

Other than the most important thing saving lives there is lots of money at stake here for the pharma's etc. It's a race to a vaccine and to therapeutic drugs. Personally, I like what I've heard and read about SNG/SNG001. CEO Richard Marsden said that 'data is king' and thats what they are concentrating on. He's right. Other drugs are falling by the wayside like Hydroxy Chloroquine and many vaccines will too. SNG are doing it all properly and in the golden standard of trials, a double blind placebo trial. With luck the results will be great and people may just be saved and shareholders will get a great return.GLA and goodnight.

80p :)

getting a bit political boys!